NEW ORLEANS, June 06, 2022–(Business WIRE)–Tandem Diabetic issues Care, Inc. (NASDAQ:TNDM), a world wide insulin supply and diabetic issues technological innovation company, declared optimistic serious-earth facts demonstrating rapid and sustained added benefits in a assorted cohort of folks applying the t:trim X2™ insulin pump with Control-IQ® know-how. The knowledge was introduced at the American Diabetes Association (ADA) 82nd Scientific Periods in New Orleans.
“Our Command-IQ know-how continues to be a wonderful equalizer for men and women with insulin-intensive diabetes, as we continually see optimistic clinical and quality-of-lifetime improvement with its use, regardless of age, ethnicity, or prior remedy,” claimed Jordan Pinsker, MD, Vice President and Medical Director for Tandem Diabetes Treatment. “This proof increases our determination to bring new innovations in technology to profit persons living with diabetes globally.”
Details presented at the convention will come from the Command-IQ Observational (CLIO) research, an ongoing real-entire world, longitudinal review of individuals using the t:slender X2 insulin pump with Control-IQ technological innovation.
Summaries of ADA Scientific Classes Shows
Psychosocial Rewards of Using Command-IQ Engineering: Extensive-term Results from a Multi-Ethnic Grownup Cohort with Variety 1 Diabetes1
Named as an ADA Presidents’ Pick out Summary Presentation, this investigation features affected person-reported outcomes from an ethnically assorted cohort of 1,306 adults. Success demonstrated sizeable improvements in diabetic issues-unique good quality of life, fulfillment with insulin delivery gadget, and reduction in diabetes-associated burden about 12 months with Handle-IQ engineering. Psychosocial rewards of Control-IQ technology were professional by all ethnic cohorts. Considerably improved excellent of sleep was also pointed out for all participants working with the procedure.
Analysis of Long-Expression Glycemic Outcomes by Ethnicity in Grownups with Kind 1 Diabetic issues Utilizing Control-IQ Technological know-how2
This examine assessed relationships amongst ethnicity, baseline HbA1c, Glucose Administration Indicator (GMI), and sensor Time in Vary (TIR) (70-180mg/dL) for 1,045 grownup CLIO contributors (Asian, Black/African American, White, and Hispanic/Latino/Spanish). GMI at study conclusion reflected glycemic enhancements for all individuals, with Black/African American individuals showing a clinically suitable .7% general reduction.
Extensive-phrase Glycemic Command in Adult Individuals Utilizing Manage-IQ Technology: Genuine-Globe Evidence3
This examine assessed baseline HbA1c and glucose administration indicator derived from sensor facts from 1,107 older people using Regulate-IQ technological innovation for 12 consecutive months. Knowledge demonstrated significant glycemic enhancements, no matter of prior therapy modality.
A number of daily injection consumers with rather significant HbA1c values initiating Manage-IQ engineering showed extraordinary and sustained glycemic enhancements. Former pump users also demonstrated fast and sustained enhancements, continuing to make on evidence that all consumers can benefit from Regulate-IQ technologies no matter of prior treatment.
“Demonstrating that our know-how rewards ethnically varied groups, irrespective of preceding treatment modality, is significant to satisfying our mission to make improvements to the lives of persons living with diabetes throughout the world,” said Steph Habif, EdD, MS, Vice President, Behavioral Sciences at Tandem Diabetic issues Treatment. “As a world wide leader in insulin treatment administration, we attempt to supply diabetes care methods that get the job done equally well across all persons residing with diabetic issues, and the details offered at this meeting is proof of our results towards this aim.”
References
1. Singh H, Alencar G, Sanchez H, et al. Psychosocial Gains of making use of the t:slender X2 Insulin Pump with Management-IQ technological know-how: Extensive-time period Outcomes from a Multi-ethnic Grownup Cohort with Type 1 Diabetes. Oral presentation at 82nd Scientific Sessions of the American Diabetes Affiliation June 3-7, 2022 New Orleans, LA.
2. Habif S, Graham R, Singh H, et al. Analysis of long-expression glycemic results by ethnicity in grownups with style 1 diabetes using the t:slender X2 insulin pump with Handle-IQ technology. Poster introduced at 82nd Scientific Classes of the American Diabetic issues Association June 3-7, 2022 New Orleans, LA.
3. Pinsker J, Graham R, Singh H, et al. Lengthy-expression Glycemic Manage in Adult Individuals Utilizing the t:trim X2 Insulin Pump with Management-IQ Technology: Serious-World Evidence. Poster presented at 82nd Scientific Classes of the American Diabetic issues Affiliation June 3-7, 2022 New Orleans, LA.
About Tandem Diabetes Treatment, Inc.
Tandem Diabetic issues Care, Inc., a global insulin shipping and diabetic issues technological innovation organization based in San Diego, California, creates new options for people today dwelling with diabetes, their loved types, and health care providers by way of a positively diverse experience. The company’s human-centered solution to style, progress, and help provides modern items and expert services for persons who use insulin. Tandem manufactures and sells the t:slim X2 insulin pump with Control-IQ know-how. For more information, stop by tandemdiabetes.com.
Comply with Tandem Diabetic issues Treatment on Twitter @tandemdiabetes use #tslimX2, #ADA2022 and $TNDM.
Follow Tandem Diabetes Treatment on Fb at fb.com/TandemDiabetes.
Abide by Tandem Diabetes Treatment on LinkedIn at linkedin.com/corporation/tandemdiabetes.
Dependable use of Management-IQ know-how
Command-IQ technological innovation does not prevent all highs and lows. Users must however bolus for meals and actively regulate their diabetes. Pay a visit to tandemdiabetes.com/safetyinfo for additional essential basic safety info.
Vital Safety Data: RX ONLY. The t:slim X2 pump and Command-IQ technology are meant for s
ingle affected individual use. The t:trim X2 pump and Management-IQ technological innovation are indicated for use with NovoLog or Humalog U-100 insulin. t:slender X2 insulin pump: The t:slim X2 insulin pump with interoperable engineering is an alternate controller enabled (ACE) pump that is meant for the subcutaneous supply of insulin, at set and variable rates, for the administration of diabetes mellitus in men and women necessitating insulin. The pump is in a position to reliably and securely connect with suitable, digitally related units, which include automatic insulin dosing software, to obtain, execute, and affirm instructions from these products. The t:slender X2 pump is indicated for use in people 6 decades of age and higher. Command-IQ know-how: Regulate-IQ technologies is meant for use with a suitable integrated ongoing glucose observe (iCGM, bought separately) and ACE pump to automatically raise, reduce, and suspend shipping and delivery of basal insulin based mostly on iCGM readings and predicted glucose values. It can also supply correction boluses when the glucose price is predicted to exceed a predefined threshold. Handle-IQ technology is supposed for the administration of Variety 1 diabetic issues mellitus in individuals six a long time of age and larger.
BOXED WARNING: Management-IQ technologies should not be utilised by anyone less than the age of six several years previous. It ought to also not be utilised in sufferers who call for fewer than 10 models of insulin for every working day or who weigh much less than 55 lbs.
Regulate-IQ engineering is not indicated for use in expecting gals, men and women on dialysis, or critically sick patients. Do not use Control-IQ technological know-how if using hydroxyurea. Users of the t:trim X2 pump and Command-IQ technological know-how ought to: use the insulin pump, CGM, and all other procedure parts in accordance with their respective guidelines for use check blood glucose degrees as suggested by their healthcare supplier reveal satisfactory carb-counting techniques retain adequate diabetes self-care skills see healthcare provider(s) regularly and have satisfactory vision and/or hearing to realize all capabilities of the pump, which include alerts, alarms, and reminders. The t:slim X2 pump, and the CGM transmitter and sensor must be taken out just before MRI, CT, or diathermy therapy. Check out tandemdiabetes.com/safetyinfo for supplemental crucial safety facts.
© 2022 Tandem Diabetic issues Treatment, Inc. All legal rights reserved. Tandem Diabetic issues Care, Command-IQ, and t:trim X2 are possibly registered logos or trademarks of Tandem Diabetes Treatment, Inc. in the United States and/or other countries. All 3rd-party marks are the property of their respective proprietors.
Perspective resource edition on businesswire.com: https://www.businesswire.com/news/dwelling/20220606005878/en/
Contacts
Media Make contact with:
Steve Sabicer
714-907-6264
[email protected]
Investor Make contact with:
Susan Morrison
858-366-6900
[email protected]